Dr. Shimon Eckhouse

Dr. Shimon Eckhouse Overview

Dr. Shimon Eckhouse is an inventor, investor and active entrepreneur in the field of medical devices and medical technology. He is a Founder, Co-Founder and investor in more than 20 companies in medical technology and other high-tech areas. He is The inventor of IPL (Intense Pulsed Light) technology, the most popular non-invasive energy based technology for a broad range of non-invasive medical aesthetic applications. In addition, Mr. Eckhouse is the author of more than 60 US-registered patents and a few hundred international patents and author of more than 50 papers in leading refereed journals and conferences. He is also a member of the Board of Governors of the Technion Israeli Institute of Technology. Dr. Eckhouse is currently the Founder, owner and Chairman of Alon Medtech incubator in Israel which is investing in early-stage start-ups in health care technologies and is part of the Israeli Innovation Authority incubator program. Alons current portfolio consists of 16 medical technology companies in fields such as cardiology, digital and personalized medicine, aesthetic medicine and minimally invasive surgery. He holds a Ph.D. in Physics from the University of California at Irvine and a B.Sc. in Physics from the Technion Israeli Institute of Technology.

Latest News

Dec 13, 2021 · en.globes.co.il

growth-positive

Shimon Eckhouse brings Epitomee Medical to TASE

Epitomee, a company founded by Dr. Shimon Eckhouse, has successfully floated on the Tel Aviv Stock Exchange. The company has developed an ingestible pill for treating obesity and delivering drugs to the stomach. Epitomee raised NIS 162 million at a valuation of NIS 632 million, with Nestlé converting a $7 million loan to equity. The pill expands in the stomach, creating a sensation of fullness, and disintegrates within a few hours. Epitomee has a marketing agreement with Nestlé Health Science, entitling it to receive $115 million in advance and milestone payments. The company plans to start commercial production and sales in early 2023. Epitomees main shareholders include Dr. Shimon Eckhouse, Chinese fund Star Concept, and companies owned by Idan Ofer and Udi Angel.

InvestmentPartners

Aug 24, 2021 · en.globes.co.il

growth-positive

Shimon Eckhouse rides again with SofWave

SofWave Medical, an aesthetic medicine company founded by Shimon Eckhouse, has been listed on the Tel Aviv Stock Exchange (TASE). The company has developed an anti-aging product for skin tightening using new ultrasound technology. Despite the challenges of launching the product during the COVID-19 pandemic, SofWave Medical has achieved successful market penetration. In the first half of 2021, the company generated $10.2 million in revenue with a gross margin of 73.8%. SofWave Medical raised NIS 160 million in its IPO at a valuation of NIS 800 million. The companys share price is currently close to the issue price. The CEO, Eckhouse, is confident in the companys potential for rapid growth and its ability to prove itself in the market.

Public TradingInvestment

Team Members

1

Web & Social Links

Photos & Videos

No files yet

Dr. Shimon Eckhouse Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info

Main Contact